Founded with the mission to save lives through the development and manufacturing of advanced therapies, the Center for Breakthrough Medicines (CBM) is a contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. CBM offers a comprehensive suite of services including process development, analytical development and testing, plasmid DNA manufacturing, viral vector manufacturing, cell therapy manufacturing, and enabling services. The company is dedicated to accelerating the delivery of life-saving treatments by providing end-to-end solutions for biopharmaceutical companies.

Notable affiliated individuals include experienced professionals in the biotech industry, though specific names are not provided. CBM has attracted significant investment from leading venture capital firms and strategic partners in the healthcare sector. Key achievements include establishing state-of-the-art facilities and forming strategic partnerships to enhance their service offerings. The overall impact of CBM lies in its contribution to the rapid advancement of cell and gene therapies, ultimately aiming to improve patient outcomes and address unmet medical needs.